SE421125B - Forfarande for framstellning av 5-m-tolyloxiuracil - Google Patents

Forfarande for framstellning av 5-m-tolyloxiuracil

Info

Publication number
SE421125B
SE421125B SE7707471A SE7707471A SE421125B SE 421125 B SE421125 B SE 421125B SE 7707471 A SE7707471 A SE 7707471A SE 7707471 A SE7707471 A SE 7707471A SE 421125 B SE421125 B SE 421125B
Authority
SE
Sweden
Prior art keywords
tolyloxiuracil
preparing
procedure
Prior art date
Application number
SE7707471A
Other languages
English (en)
Swedish (sv)
Other versions
SE7707471L (sv
Inventor
C A Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7707471L publication Critical patent/SE7707471L/xx
Publication of SE421125B publication Critical patent/SE421125B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
SE7707471A 1976-07-16 1977-06-28 Forfarande for framstellning av 5-m-tolyloxiuracil SE421125B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (2)

Publication Number Publication Date
SE7707471L SE7707471L (sv) 1978-01-17
SE421125B true SE421125B (sv) 1981-11-30

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7707471A SE421125B (sv) 1976-07-16 1977-06-28 Forfarande for framstellning av 5-m-tolyloxiuracil

Country Status (29)

Country Link
US (1) US4080454A (es)
JP (1) JPS5337673A (es)
AR (1) AR213652A1 (es)
AT (1) AT351561B (es)
BE (1) BE856710A (es)
CA (1) CA1061788A (es)
CH (1) CH622512A5 (es)
CS (1) CS212264B2 (es)
DD (1) DD131556A5 (es)
DE (1) DE2731736A1 (es)
DK (1) DK139029B (es)
EG (1) EG12762A (es)
ES (1) ES460686A1 (es)
FI (1) FI772183A (es)
FR (1) FR2358399A1 (es)
GB (1) GB1542178A (es)
GR (1) GR68686B (es)
HU (1) HU177713B (es)
IL (1) IL52409A (es)
LU (1) LU77764A1 (es)
NL (1) NL7707729A (es)
NO (1) NO772489L (es)
PH (1) PH13190A (es)
PL (1) PL103783B1 (es)
PT (1) PT66808B (es)
SE (1) SE421125B (es)
SU (1) SU673169A3 (es)
YU (1) YU171677A (es)
ZA (1) ZA773927B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
JPS5822406U (ja) * 1981-08-04 1983-02-12 トキコ株式会社 消音器
KR101452518B1 (ko) 2005-08-22 2014-10-21 멜리어 파마슈티칼스 아이, 인코포레이티드 Lyn 키나제 활성의 조절 및 관련된 장애의 치료를 위한방법 및 제제
JP2010518860A (ja) * 2007-02-20 2010-06-03 メリオール・ファーマスーティカルズ・ワン・インコーポレイテッド Lynキナーゼの活性化剤の同定方法
US20100197710A1 (en) * 2007-07-23 2010-08-05 Melior Pharmaceuticals I, Inc. Methods Of Activating IRS-1 And AKT
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (en) * 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prevention of pancreatic beta cell degeneration
CN110785170B (zh) 2017-04-10 2023-03-28 梅里奥尔医药I公司 脂肪细胞的治疗
AU2019223911A1 (en) 2018-02-21 2020-07-23 Melior Pharmaceuticals I, Inc. Treatment of liver diseases

Also Published As

Publication number Publication date
AR213652A1 (es) 1979-02-28
LU77764A1 (es) 1978-02-02
NL7707729A (nl) 1978-01-18
JPS5337673A (en) 1978-04-06
AT351561B (de) 1979-08-10
PL103783B1 (pl) 1979-07-31
GB1542178A (en) 1979-03-14
CA1061788A (en) 1979-09-04
ZA773927B (en) 1978-05-30
SU673169A3 (ru) 1979-07-05
YU171677A (en) 1982-06-30
CS212264B2 (en) 1982-03-26
BE856710A (fr) 1978-01-11
DK139029B (da) 1978-12-04
PH13190A (en) 1980-01-16
FR2358399B1 (es) 1980-10-17
NO772489L (no) 1978-01-17
SE7707471L (sv) 1978-01-17
DD131556A5 (de) 1978-07-05
US4080454A (en) 1978-03-21
PL199633A1 (pl) 1978-04-10
FR2358399A1 (fr) 1978-02-10
DK139029C (es) 1979-05-07
AU2663877A (en) 1978-05-18
PT66808B (en) 1978-12-21
JPS5512017B2 (es) 1980-03-29
IL52409A (en) 1979-11-30
ES460686A1 (es) 1978-12-01
EG12762A (en) 1979-12-31
DK318177A (es) 1978-01-17
FI772183A (es) 1978-01-17
IL52409A0 (en) 1977-08-31
ATA509277A (de) 1979-01-15
CH622512A5 (es) 1981-04-15
PT66808A (en) 1977-08-01
DE2731736A1 (de) 1978-01-26
HU177713B (en) 1981-12-28
GR68686B (es) 1982-02-01

Similar Documents

Publication Publication Date Title
SE440791B (sv) Forfarande for upparbetning av lignitkol
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
RO70569A (ro) Procedeu pentru prepararea alchilaminelor heterociclice
SE7808485L (sv) Forfarande for framstellning av oligoimider
FI773719A (fi) Anordning foer avskiljande av en fiberbana
SE425972B (sv) Forfarande for framstellning av karbamid
SE7708384L (sv) Forfarande for dekoffeinering av kaffe
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
SE7704949L (sv) Forfarande for framstellning av emulsioner
SE7807240L (sv) Forfarande for framstellning av para-bensokinon
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
IT1076788B (it) Procedimento per preparare organopolisilossani
SE442195B (sv) Forfarande for framstellning av etrar
SE7704139L (sv) Forfarande for framstellning av azofergemnen
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
TR19495A (tr) Huecre kueltuerue yapilmasina mahsus usul
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE7709806L (sv) Forfarande for framstellning av peptider
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
SE440903B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-aminopropaner
SE7605853L (sv) Forfarande for framstellning av en antidiuretiskt verksam polypeptid